NCT05158491 2022-01-05Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLCJenKem Technology Co., Ltd.Phase 1/2 Unknown63 enrolled
NCT01876446 2020-03-17Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung CancerRoswell Park Cancer InstitutePhase 2 Completed38 enrolled 16 charts